![Jay Parrish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Parrish
Vorstandsvorsitzender bei
Pretzel Therapeutics, Inc.
Profil
Jay Parrish was the founder of Vir Biotechnology, Inc. (2016), serving as Chief Business Officer from 2017 to 2021.
Dr. Parrish is the founder of Rome Therapeutics, Inc. (2019), serving as Director since 2019.
Current jobs include Chairman & Chief Executive Officer at Pretzel Therapeutics, Inc. since 2021, Director at Interline Therapeutics, Inc. since 2021, Venture Partner at ARCH Venture Partners LLC since 2016, and Advisor at Orbital Therapeutics, Inc. since 2022.
Former jobs include Director at Guide Therapeutics, Inc. from 2020 to 2021 and Advisor at Abide Therapeutics, Inc. from 2009 to 2011.
Education includes an undergraduate degree from Emory University (1996), a doctorate from the University of South Florida (2001), and an MBA from Haas School of Business (2011).
Aktive Positionen von Jay Parrish
| Unternehmen | Position | Beginn |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private-Equity-Analyst | 01.05.2016 |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Gründer | 01.05.2019 |
Pretzel Therapeutics, Inc.
 Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Provides mitochondrial biology solutions | Vorstandsvorsitzender | 01.04.2021 |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Berater | 01.06.2022 |
Interline Therapeutics, Inc.
 Interline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Direktor/Vorstandsmitglied | 01.05.2021 |
Ehemalige bekannte Positionen von Jay Parrish
| Unternehmen | Position | Ende |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Gründer | 01.04.2021 |
Guide Therapeutics, Inc.
 Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Direktor/Vorstandsmitglied | 01.02.2021 |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Berater | 01.04.2011 |
Ausbildung von Jay Parrish
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Guide Therapeutics, Inc.
Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Health Technology |
Interline Therapeutics, Inc.
Interline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Pretzel Therapeutics, Inc.
Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Provides mitochondrial biology solutions | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
Wählen Sie MarketScreener 
